Search

Search Constraints

You searched for: Author/Creator Orlando, R.

Search Results

11. OC.12.2 THE REAL-WORLD LONG-TERM EFFECTIVENESS OF VEDOLIZUMAB IN INFLAMMATORY BOWEL DISEASES: A SINGLE CENTER OBSERVATIONAL STUDY. (25th March 2019)

12. OC.12.3 SPOSIB SB2 – A SICILIAN PROSPECTIVE OBSERVATIONAL STUDY OF PATIENTS WITH INFLAMMATORY BOWEL DISEASE TREATED WITH INFLIXIMAB BIOSIMILAR SB2 (FLIXABI®): INTERIM ANALYSIS. (25th March 2019)

13. P.02.4 EFFECTIVENESS OF VEDOLIZUMAB ON INTESTINAL AND ARTICULAR OUTCOMES: REAL-WORLD DATA FROM THE SICILIAN NETWORK FOR INFLAMMATORY BOWEL DISEASE (SN-IBD). Issue 2 (15th March 2018)

14. P.11.3: Poor Tolerability Profile of Thiopurines in Inflammatory Bowel Disease: A Prospective Single-Centre Experience. (15th March 2017)

15. PC.01.2 A PROPENSITY SCORE WEIGHTED COMPARISON OF VEDOLIZUMAB AND ADALIMUMAB IN CROHN'S DISEASE: REAL-LIFE DATA FROM THE SICILIAN NETWORK FOR INFLAMMATORY BOWEL DISEASE (SN-IBD). (1st October 2020)

16. Seroprevalence of SARS-CoV-2 antibodies, associated epidemiological factors and antibody kinetics among healthcare workers in Connecticut. (August 2021)

18. The bacterial quorum sensing molecule, 2-heptyl-3-hydroxy-4-quinolone (PQS), inhibits signal transduction mechanisms in brain tissue and is behaviorally active in mice. (August 2021)